Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 1000 for query «pharma»

14 December, 2017 12:23 PM Natco Pharma raises Rs 915 crore via QIP

Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors, according to a regulatory filing. During its meeting on Thursday, the company's committee of directors decided to allocate 1 crore shares at issue price of Rs 915 apiece, Natco Pharma said. The shares were allotted to eligible qualified institutional 29

12 December, 2017 4:21 AM Dr Reddy's Lab up 6% on establishment inspection report from USFDA for Bachupally unit

Dr Reddy's Laboratories shares rallied as much as 6 percent in morning Tuesday on getting clearance to Bachupally plant. The pharma major informed exchanges that it has received an establishment inspection report from the US Food and Drug Administration on Monday after closure of audit of Bachupally unit, Hyderabad. In April, the USFDA conducted an audit 39

11 December, 2017 6:38 AM Granules' arm completes audit with USFDA

Pharma firm Granules India today said its US subsidiary has received an observation from the USFDA on completion of inspection. "Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Chantilly, Virginia, US completed its first audit from December 4-8, 2017 by the USFDA (US Food and Drug Administration) with one observation 46

9 December, 2017 10:31 AM Pharma Weekly Wrap: Pharma stocks rebound this week on buying interest

The hospital stocks remained stable despite the ongoing developments related to Delhi government cancelling license of Max Hospital Shalimar Bagh and Harayana government removing Gurugram’s Fortis Hospital from the list of empanelled hospitals. Most pharma stocks recovered this week on back of renewed buying interest. Biocon continues to be the pick of the week as the company's 39

6 December, 2017 2:53 AM Stocks in the news: Sun Pharma, IDBI Bank, Federal Bank, Shilpa Medicare, Bharat Fin

Sun Pharma | Aurobindo Pharma | IDBI Bank | Federal Bank | Shilpa Medicare | Reliance Communications | Bharat Financial Inclusion | Lanco Infratech | Amtek Auto | Plastiblends | Lux Industries and Byke Hospitality are stocks, which are in the news today. Sun Pharma Gets Tentative US FDA Nod For Tadalfil Tablets (2.5-20 mg) (Used To Treat Erectile Dysfunction 27

1 December, 2017 8:49 AM Buy Natco Pharma, Jubilant Life; sell IRB Infrastructure, Tata Steel, Voltas: Ashwani Gujral

Ashwani Gujral of is of the view that one can buy Natco Pharma and Jubilant Life Sciences and sell IRB Infrastructure, Tata Steel and Voltas. Ashwani Gujral of told CNBC-TV18, "Natco Pharma is the buy with a stop loss of Rs 960 and target of Rs 995. IRB Infrastructure is a sell with a stop loss of Rs 230 and target 37

1 December, 2017 6:02 AM Glenmark gets approval for inhaler product in Nordic region

Glenmark Pharmaceuticals Europe Ltd today said it has received approval for an inhaled respiratory product in Nordic countries, including Sweden, Denmark, Norway, Finland and Iceland. The company "has successfully closed the decentralised registration procedure for generic Seretide Accuhaler in the Nordic region", Glenmark Pharma said in BSE filing 33

29 November, 2017 3:23 AM Competition will help diagnostic industry to consolidate: Metropolis

“We have seen lot more competition than there was before, lot more funding, lot more aspiration. It is good for the industry. Hopefully it will also help it consolidate, get more organised, get little more regulation, these are positive things for the industry,� Ameera Shah, MD of Metropolis said. Not in a hurry to hit the markets, that's the word coming 38

28 November, 2017 10:49 AM Sensex breaks 8-day rally as GDP data looms

Breaking eight sessions of gains, the Sensexfell 106 points as investors took profit and adopted a cautious approach ahead of September-quarter GDP data. Consumer durables, pharma and oil & gas and PSU stocks suffered losses. The 30-share Sensex after opening a shade higher quickly slipped into the red, but settled down 105.85 points, or 0.31 per cent at 33,618.59. The index 38

28 November, 2017 5:14 AM Glenmark Pharma gets 7 observations from USFDA for Baddi unit

Glenmark Pharmaceuticals today said the US health regulator has made seven observations after an audit at its Baddi manufacturing unit. Glenmark said its Baddi unit contributes approximately 10 per cent of the revenue of the US sales. "The Baddi unit of Glenmark Pharmaceuticals underwent an US FDA (US Food and Drug Administration) audit from November 42